SCHEMBL20042363

SCHEMBL20042363

CCc1cnc2c(ccc3cc(CC)cnc32)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.56
CCR1 P32246 2/20 0.52
CCR5 P51681 2/20 0.52
CCR8 P51685 2/20 0.52
CYP1A2 P05177 1/20 0.45
CYP2A6 P11509 1/20 0.45
KCNH2 Q12809 2/20 0.39
HRH4 Q9H3N8 2/20 0.39
HRH3 Q9Y5N1 2/20 0.39
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
HRH2 P25021 1/20 0.36
HRH1 P35367 1/20 0.36
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
AKR1C3 P42330 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15581734 0.87 PARP1 (0.47) PARP1CCR1CCR5CCR8CYP1A2
SCHEMBL22824281 0.87 CCR1 (0.62) PARP1CCR1CCR5CCR8CYP1A2
SCHEMBL10390686 0.84 PARP1 (0.44) PARP1CCR1CCR5CCR8CYP1A2
SCHEMBL20036792 0.82 PARP1 (0.49) PARP1CCR1CCR5CCR8CYP1A2
SCHEMBL10706774 0.82 PARP1 (0.46) PARP1CCR1CCR5CCR8CYP1A2
SCHEMBL31490370 0.82 PARP1 (0.46) PARP1CCR1CCR5CCR8CYP1A2
SCHEMBL5094347 0.81 PARP1 (0.59) PARP1CCR1CCR5CCR8CYP1A2
SCHEMBL6171961 0.81 PARP1 (0.59) PARP1CCR1CCR5CCR8CYP1A2
SCHEMBL31026571 0.79 NPC1 (0.45) PARP1CCR1CCR5CCR8CYP1A2
SCHEMBL3709715 0.79 PARP1 (0.57) PARP1CCR1CCR5CCR8CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180102484-A1 NEW COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180102484-A1 NEW COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE CBX8, MLX, HAX1 PARP1 3849/4885CCR1 233/4885CCR5 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.